191 related articles for article (PubMed ID: 12960839)
1. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
2. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
5. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
6. Control of human herpes virus type 8-associated diseases by NK cells.
Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
8. HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluation.
Lorenzen T; Albrecht D; Paech V; Meyer T; Hoffmann C; Stoehr A; Degen O; Stellbrink HJ; Meigel WN; Arndt R; Plettenberg A
Eur J Med Res; 2002 Jun; 7(6):283-6. PubMed ID: 12117665
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
10. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
[TBL] [Abstract][Full Text] [Related]
11. [Kaposi's sarcoma].
Boué F; Lebbé C
Bull Cancer; 2003 May; 90(5):393-8. PubMed ID: 12850761
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.
Gnann JW; Pellett PE; Jaffe HW
Clin Infect Dis; 2000 Apr; 30 Suppl 1():S72-6. PubMed ID: 10770915
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma of the recto sigmoid colon in a patient with HIV infection and a high CD4 count.
Acharya S; Ross JD
Int J STD AIDS; 2007 Jul; 18(7):499-500. PubMed ID: 17623511
[TBL] [Abstract][Full Text] [Related]
14. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
[TBL] [Abstract][Full Text] [Related]
15. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
Chan DJ
Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
[No Abstract] [Full Text] [Related]
17. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.
Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847
[TBL] [Abstract][Full Text] [Related]
19. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
Loke WC; Spittle MF; Mitchell S; Kulasegaram R
Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
[TBL] [Abstract][Full Text] [Related]
20. Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis.
di Gennaro G; Canzonieri V; Schioppa O; Nasti G; Carbone A; Tirelli U
Clin Infect Dis; 2001 Apr; 32(7):1100-2. PubMed ID: 11264040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
